4//SEC Filing
Vargeese Chandra 4
Accession 0000899243-21-007203
CIK 0001631574other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 7:14 PM ET
Size
9.9 KB
Accession
0000899243-21-007203
Insider Transaction Report
Form 4
Vargeese Chandra
See Remarks
Transactions
- Award
Ordinary Shares
2021-02-01+50,000→ 88,557 total - Sale
Ordinary Shares
2021-02-16$10.57/sh−3,145$33,243→ 85,412 total - Award
Share Option (right to buy)
2021-02-01+50,000→ 50,000 totalExercise: $10.48Exp: 2031-02-01→ Ordinary Shares (50,000 underlying)
Footnotes (5)
- [F1]Consists of restricted share units (RSUs). The RSUs vest in two equal installments on February 15, 2022 and February 15, 2023.
- [F2]Includes 1,500 ordinary shares acquired under the issuer's 2019 Employee Share Purchase Plan (ESPP) on January 14, 2021.
- [F3]On February 16, 2021, the reporting person sold 3,145 ordinary shares solely to cover taxes associated with the vesting of RSUs on February 15, 2021. These sales were made pursuant to a 10b5-1 Trading Plan.
- [F4]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $10.49 to $10.58 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F5]The option vests as to 50% of the shares on February 15, 2022 and 50% on February 15, 2023.
Documents
Issuer
Wave Life Sciences Ltd.
CIK 0001631574
Entity typeother
Related Parties
1- filerCIK 0001657675
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 7:14 PM ET
- Size
- 9.9 KB